Association of hormonal contraception with depression

JAMA Psychiatry

Volumn 73, Issue 11, 2016, Pages 1154-1162

  Skovlund, Charlotte Wessel ^a   Mørch, Lina Steinrud ^a   Kessing, Lars Vedel ^a   Lidegaard, Ojvind ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CONTRACEPTIVE AGENT; GESTAGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DENMARK; DEPRESSION; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFERTILITY; MENTAL HOSPITAL; NEOPLASM; OUTPATIENT; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS; RISK FACTOR; VAGINA RING; VEIN THROMBOSIS; AGE; CHEMICALLY INDUCED; COHORT ANALYSIS; PROSPECTIVE STUDY; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; COHORT STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; DENMARK; DEPRESSIVE DISORDER; FEMALE; HUMANS; PROSPECTIVE STUDIES; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84997765964     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.2387     Document Type: Article

References (47)

1. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382 (9904):1575-1586.
2. Desai HD, JannMW. Major depression in women: A review of the literature. J AmPharm Assoc (Wash). 2000;40(4):525-537.
3. Piccinelli M, Wilkinson G. Gender differences in depression: critical review. Br J Psychiatry. 2000; 177:486-492.
4. Noble RE. Depression in women. Metabolism. 2005;54(5)(suppl 1):49-52.
5. Hammarström A, Lehti A, Danielsson U, Bengs C, Johansson EE. Gender-related explanatory models of depression: A critical evaluation of medical articles. Public Health. 2009;123(10):689-693.
6. Kessler RC, McGonagle KA, SwartzM, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993;29(2-3):85-96.
7. Wesselhoeft R, Pedersen CB, Mortensen PB, Mors O, Bilenberg N. Gender-Age interaction in incidence rates of childhood emotional disorders. Psychol Med. 2015;45(4):829-839.
8. Joffe H, Cohen LS. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry. 1998;44(9):798-811.
9. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338(4):209-216.
10. McEwen BS. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol (1985). 2001;91(6): 2785-2801.
11. Hall KS, White KO, Rickert VI, Reame N, Westhoff C. Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women. Contraception. 2012;86(5): 518-525.
12. Inoue K, Barratt A, Richters J. Does research into contraceptivemethod discontinuation address womens own reasons? a critical review. J Fam Plann Reprod Health Care. 2015;41(4):292-299.
13. Toffoletto S, Lanzenberger R, Gingnell M, Sundström-Poromaa I, Comasco E. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: A systematic review. Psychoneuroendocrinology. 2014;50:28-52.
14. Gingnell M, Engman J, Frick A, et al. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill: A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology. 2013;38 (7):1133-1144.
15. Holst J, Bäckström T, Hammarbäck S, von Schoultz B. Progestogen addition during oestrogen replacement therapy: effects on vasomotor symptoms and mood. Maturitas. 1989;11 (1):13-20.
16. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab. 1991;72(2):336-343.
17. Andréen L, Nyberg S, Turkmen S, van Wingen G, Fernández G, Bäckström T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology. 2009;34(8):1121-1132.
18. Klaiber EL, Broverman DM, VogelW, Peterson LG, Snyder MB. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. Psychoneuroendocrinology. 1996;21(7):575-592.
19. Payne JL. The role of estrogen in mood disorders inwomen. Int Rev Psychiatry. 2003;15(3):280-290.
20. Young EA, Midgley AR, Carlson NE, Brown MB. Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatry. 2000;57(12):1157-1162.
21. Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014; 71(1):36-43.
22. Frokjaer VG, Pinborg A, Holst KK, et al. Role of serotonin transporter changes in depressive responses to sex-steroid hormone manipulation: A positron emission tomography study. Biol Psychiatry. 2015;78(8):534-543.
23. Duke JM, Sibbritt DW, Young AF. Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception. 2007;75(1):27-31.
24. Wiréhn AB, Foldemo A, Josefsson A, Lindberg M. Use of hormonal contraceptives in relation to antidepressant therapy: A nationwide population-based study. Eur J Contracept Reprod Health Care. 2010;15(1):41-47.
25. Toffol E, Heikinheimo O, Koponen P, Luoto R, Partonen T. Hormonal contraception and mental health: results of a population-based study. Hum Reprod. 2011;26(11):3085-3093.
26. Lindberg M, Foldemo A, Josefsson A, Wiréhn AB. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: A nationwide population-based study with age-specific analyses. Eur J Contracept Reprod Health Care. 2012;17(2): 106-118.
27. Toffol E, Heikinheimo O, Koponen P, Luoto R, Partonen T. Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception. 2012;86(5):470-480.
28. Keyes KM, Cheslack-Postava K, Westhoff C, et al. Association of hormonal contraceptive use with reduced levels of depressive symptoms: A national study of sexually activewomen in the United States. AmJ Epidemiol. 2013;178(9):1378-1388.
29. Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons. Am J Obstet Gynecol. 1998; 179(3, pt 1):577-582.
30. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64(1):51-58.
31. Poromaa IS, Segebladh B. Adverse mood symptoms with oral contraceptives. Acta Obstet Gynecol Scand. 2012;91(4):420-427.
32. Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke andmyocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257-2266.
33. Nielsen LH, Løkkegaard E, Andreasen AH, Keiding N. Using prescription registries to define continuous drug use: how to fill gaps between prescriptions. Pharmacoepidemiol Drug Saf. 2008; 17(4):384-388.
34. Van den HeuvelMW, van Bragt AJM, Alnabawy A, et al. Comparison of ethinylestradiol pharmacokinetics in the transdermal patch, and an oral contraceptive. Contraception. 2005;72(3): 168-174.
35. ESHRE CapriWorkshop Group. Intrauterine devices and intrauterine systems. Hum Reprod Update. 2008;14(3):197-208.
36. Young 2006: 15-To 24-year olds sexuality: knowledge, attitudes and behavior [in Danish]. https://sundhedsstyrelsen.dk/~/media/2618A20A8D7742F99DF82A971020DD7B.ashz. Accessed June 1, 2016.
37. Survey of 11-15 year-old lifestyle and health habits 1997-2008. http://www.sst.dk/~/media/BBDFA57CB8CD47E99B08F6328429C538.ashx. Accessed June 1, 2016.
38. BorW, Dean AJ, Najman J, Hayatbakhsh R. Are child and adolescent mental health problems increasing in the 21st century? a systematic review. Aust N Z J Psychiatry. 2014;48(7):606-616.
39. Thielen K, Nygaard E, Andersen I, et al. Misclassification and the use of register-based indicators for depression. Acta Psychiatr Scand. 2009;119(4):312-319.
40. Henriksson S, Boëthius G, Hakansson J, Isacsson G. Indications for and outcome of antidepressant medication in a general population: A prescription database and medical record study, in Jämtland County, Sweden, 1995. Acta Psychiatr Scand. 2003;108(6):427-431.
41. Patten SB, Esposito E, Carter B. Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol Drug Saf. 2007;16(7): 746-752.
42. Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TMM. The effects of steroidal contraceptives on the well-being and sexuality of women: A double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception. 1995;52(6):363-369.
43. OConnell K, Davis AR, Kerns J. Oral contraceptives: side effects and depression in adolescent girls. Contraception. 2007;75(4):299-304.
44. Akm B, Ege E, Aksöllö N, Demirören N, Erdem H. Combined oral contraceptives use and relationship with depressive symptoms in Turkey. Sex Disabil. 2010;28:265-273.
45. Kulkarni J. Depression as a side effect of the contraceptive pill. Expert Opin Drug Saf. 2007;6(4): 371-374.
46. Svendal G, Berk M, Pasco JA, Jacka FN, Lund A, Williams LJ. The use of hormonal contraceptive agents and mood disorders inwomen. J Affect Disord. 2012;140(1):92-96.
47. Cheslack-Postava K, Keyes KM, Lowe SR, Koenen KC. Oral contraceptive use and psychiatric disorders in a nationally representative sample of women. ArchWomens Ment Health. 2015;18(1): 103-111.